InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Insley Thomas, Chief Financial Officer. Insider active across 1 company, notably Dermata Therapeutics, Inc.. Cumulatively, 1 reports have been logged. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Thomas Insley is the Chief Financial Officer of Dermata Therapeutics, Inc., a biopharmaceutical company. In this role, he oversees the financial management of the company, including financial planning and analysis. With expertise in finance, he contributes to the company's financial strategy.